Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book offers an excellent introduction to the use of novel therapeutic vaccines for common diseases based on their ability to induce antibody production. While the role of vaccines in the treatment of infectious diseases and cancer is well known, vaccines have also recently been developed for a variety of other conditions, including Alzheimer’s disease, hypertension, diabetes, and spondyloarthritis. These therapeutic advances are fully and clearly documented by acknowledged experts in the field, who explain the relevant biology and highlight the challenges involved in deploying this…mehr
This book offers an excellent introduction to the use of novel therapeutic vaccines for common diseases based on their ability to induce antibody production. While the role of vaccines in the treatment of infectious diseases and cancer is well known, vaccines have also recently been developed for a variety of other conditions, including Alzheimer’s disease, hypertension, diabetes, and spondyloarthritis. These therapeutic advances are fully and clearly documented by acknowledged experts in the field, who explain the relevant biology and highlight the challenges involved in deploying this treatment approach effectively and safely. In addition, recent progress in the construction and delivery of DNA vaccines is documented, and the process of developing new peptide vaccines is explored in depth. While the book will be particularly valuable for researchers and scholars interested in immunotherapy, it will also appeal to clinicians seeking effective new medicines to treat patientssuffering from chronic diseases.
Hironori Nakagami, M.D. Ph.D. Osaka University, Dept. of Health Development and Medicine, Japan
Inhaltsangabe
Chapter 1.Overview about the concept of therapeutic vaccine.- Chapter 2.Immunotherapy for Tau and amyloid beta against Alzheimer disease.- Chapter 3.Therapeutic vaccine for cardiovascular diseases.- Chapter 4.Immunotherapy for obesity.- Chapter 5.Immunotherapy for spondyloarthritis.- Chapter 6.Recent progress of DNA vaccine.- Chapter 7.Translational research of novel peptide vaccine.- Chapter 8.Conclusion
Chapter 1.Overview about the concept of therapeutic vaccine.- Chapter 2.Immunotherapy for Tau and amyloid beta against Alzheimer disease.- Chapter 3.Therapeutic vaccine for cardiovascular diseases.- Chapter 4.Immunotherapy for obesity.- Chapter 5.Immunotherapy for spondyloarthritis.- Chapter 6.Recent progress of DNA vaccine.- Chapter 7.Translational research of novel peptide vaccine.- Chapter 8.Conclusion
Chapter 1.Overview about the concept of therapeutic vaccine.- Chapter 2.Immunotherapy for Tau and amyloid beta against Alzheimer disease.- Chapter 3.Therapeutic vaccine for cardiovascular diseases.- Chapter 4.Immunotherapy for obesity.- Chapter 5.Immunotherapy for spondyloarthritis.- Chapter 6.Recent progress of DNA vaccine.- Chapter 7.Translational research of novel peptide vaccine.- Chapter 8.Conclusion
Chapter 1.Overview about the concept of therapeutic vaccine.- Chapter 2.Immunotherapy for Tau and amyloid beta against Alzheimer disease.- Chapter 3.Therapeutic vaccine for cardiovascular diseases.- Chapter 4.Immunotherapy for obesity.- Chapter 5.Immunotherapy for spondyloarthritis.- Chapter 6.Recent progress of DNA vaccine.- Chapter 7.Translational research of novel peptide vaccine.- Chapter 8.Conclusion
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497